Meghmani Organics Reschedules Board Meeting to May 14, 2026 for FY26 Audited Financial Results
Meghmani Organics has rescheduled its Board of Directors meeting to May 14, 2026, from the date previously communicated on April 20, 2026. The meeting will consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, along with statutory auditors' reports. The disclosure was made in compliance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Meghmani Organics has informed the stock exchanges that its Board of Directors meeting has been rescheduled to Thursday, May 14, 2026. The company had originally communicated the meeting date via an intimation dated April 20, 2026. The revised schedule has been disclosed in accordance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Agenda for the Rescheduled Board Meeting
The Board meeting on May 14, 2026 will take up the following items for consideration and approval:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026 |
| Auditor Reports: | Reports of the Statutory Auditors on the above financial results |
| Other Business: | Any other business with the permission of the Chair |
Regulatory Compliance
The rescheduling intimation has been issued under Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Jayesh Patel, Company Secretary & Compliance Officer (ICSI Mem. No.: A14898), on May 05, 2026. The communication was addressed to both the National Stock Exchange of India Limited and BSE Limited.
What factors could have prompted Meghmani Organics to reschedule its Board meeting, and could this signal any underlying operational or financial challenges?
How have Meghmani Organics' revenue and profitability trends evolved over FY2026 compared to the previous fiscal year, and what guidance might management provide for FY2027?
Given the agrochemical sector's exposure to monsoon patterns and global commodity cycles, how might Meghmani Organics' FY2026 results reflect broader industry headwinds or tailwinds?

































